Description

BPC-157 TB-500 5mg blend research material combines BPC-157 (Body Protection Compound-157) and TB-500 (Thymosin Beta-4 fragment) at 5mg + 5mg concentration in a 3ml vial, supplied for laboratory and non-clinical investigation of tissue-repair research pathways.

What Is the BPC-157 TB-500 5mg Blend

This BPC-157 TB-500 5mg blend pairs a synthetic pentadecapeptide derived from a gastric-protective protein with a synthetic fragment of the naturally occurring protein thymosin beta-4. The formulation is used by laboratories investigating overlapping and complementary mechanisms in tissue-repair, angiogenesis, and cellular-migration research models, offering a lower-concentration option for comparative dosing-pathway research alongside the standard 10mg+10mg formulation.

Research Applications (laboratory / non-clinical research only)

• Animal model research into soft-tissue and tendon-repair mechanisms
• In vitro studies of angiogenesis and vascular endothelial growth factor pathways
• Preclinical investigation of cellular migration and wound-closure modeling
• Comparative research into concentration-dependent peptide blend research pathways
• Laboratory studies of gastrointestinal mucosal research models

Quality & Sourcing

This BPC-157 TB-500 5mg blend research material is manufactured to high purity standards and verified by HPLC (High-Performance Liquid Chromatography) analysis. Each batch is lyophilized for stability, and a Certificate of Analysis (COA) is available on request confirming peptide identity and purity. Material is intended for use by qualified researchers in controlled laboratory environments only.

Supplied As

Supplied as a lyophilized 5mg + 5mg blend in a 3ml vial, suitable for standard laboratory reconstitution procedures performed by trained personnel for research purposes.

Molecular Characteristics

This lower-concentration BPC-157 TB-500 blend combines the same two peptides found in the standard 10mg+10mg formulation, at half the concentration per vial. BPC-157 is a synthetic pentadecapeptide derived from a gastric-protective protein, while TB-500 represents the active fragment of thymosin beta-4. Offering a lower-concentration option allows researchers to design dose-ranging studies without requiring separate procurement of each peptide individually, and both components are supplied together as a lyophilized powder to preserve stability during storage.

Handling & Storage Considerations

Lyophilized BPC-157 TB-500 5mg blend material should be stored in a freezer (-20°C or below), protected from light and moisture, until the researcher is ready to reconstitute the material for a laboratory protocol. Once reconstituted with bacteriostatic water, the solution is generally stored refrigerated (2-8°C) and used within the window supported by internal stability testing. As with other combination peptide blends, repeated freeze-thaw cycles and prolonged room-temperature exposure are generally avoided to preserve research-grade integrity across a study timeline.

Common Research Design Considerations

Researchers investigating this lower-concentration blend often design dose-ranging animal-model studies to characterize soft-tissue and tendon-repair mechanisms across different concentration levels, comparing outcomes against the standard 10mg+10mg formulation. In vitro research frequently uses cultured cell models to assess cellular migration, angiogenesis markers, and wound-closure rates at varying peptide concentrations. Comparative study designs often examine this blend alongside individually administered BPC-157 and TB-500 to characterize concentration-dependent and combined-peptide research outcomes.

Frequently Asked Questions

Is this compound stable at room temperature?
Short-term handling at room temperature during active laboratory use is generally acceptable, but the lyophilized material should be returned to frozen storage promptly to preserve research-grade integrity.

What purity level should researchers expect?
Material is verified by HPLC analysis at the time of batch testing, with purity data available via the accompanying Certificate of Analysis.

Is a Certificate of Analysis provided?
Yes, a COA is available on request for each batch, confirming identity and purity for research documentation purposes.

Related Compounds

Researchers investigating this lower-concentration blend often also study the standard 10mg+10mg BPC-157 TB-500 formulation, as well as related combination products such as Klow and Glow, to compare concentration-dependent and multi-compound tissue-repair research outcomes.

For research use only. Not for human or veterinary use. Not a drug, supplement, or therapeutic product. Not intended to diagnose, treat, cure, or prevent any condition.